Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2015 4
2016 3
2017 3
2018 7
2019 16
2020 14
2021 9
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Endemic Kaposi's Sarcoma.
Zeinaty PE, Lebbé C, Delyon J. Zeinaty PE, et al. Among authors: delyon j. Cancers (Basel). 2023 Jan 31;15(3):872. doi: 10.3390/cancers15030872. Cancers (Basel). 2023. PMID: 36765830 Free PMC article. Review.
Atypical BRAF and NRAS Mutations in Mucosal Melanoma.
Dumaz N, Jouenne F, Delyon J, Mourah S, Bensussan A, Lebbé C. Dumaz N, et al. Among authors: delyon j. Cancers (Basel). 2019 Aug 8;11(8):1133. doi: 10.3390/cancers11081133. Cancers (Basel). 2019. PMID: 31398831 Free PMC article. Review.
Managing immune checkpoint inhibition in transplant recipients.
Lebbé C, Biard L, Delyon J, Zuber J. Lebbé C, et al. Among authors: delyon j. Lancet Oncol. 2022 Aug;23(8):969-971. doi: 10.1016/S1470-2045(22)00395-3. Epub 2022 Jul 6. Lancet Oncol. 2022. PMID: 35809596 No abstract available.
Management of immune-related adverse events resulting from immune checkpoint blockade.
Baroudjian B, Arangalage D, Cuzzubbo S, Hervier B, Lebbé C, Lorillon G, Tazi A, Zalcman G, Bouattour M, Lioté F, Gautier JF, Brosseau S, Lourenco N, Delyon J; PATIO group. Baroudjian B, et al. Among authors: delyon j. Expert Rev Anticancer Ther. 2019 Mar;19(3):209-222. doi: 10.1080/14737140.2019.1562342. Epub 2019 Jan 9. Expert Rev Anticancer Ther. 2019. PMID: 30572735 Review.
[Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment].
Arangalage D, Pavon AG, Hugelshofer S, Desgraz B, Tzimas G, Delyon J, Muller O, Obeid M, Ribi C, Michielin O, Özdemir BC, Monney P. Arangalage D, et al. Among authors: delyon j. Rev Med Suisse. 2020 Jun 3;16(696):1165-1168. Rev Med Suisse. 2020. PMID: 32496706 Review. French.
Severe gastrointestinal toxicity of MEK inhibitors.
Mourad N, Lourenço N, Delyon J, Eftekhari P, Bertheau P, Allayous C, Ballon A, Pagès C, Allez M, Lebbé C, Baroudjian B; PATIO group. Mourad N, et al. Among authors: delyon j. Melanoma Res. 2019 Oct;29(5):556-559. doi: 10.1097/CMR.0000000000000618. Melanoma Res. 2019. PMID: 31095035
64 results